Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...

The U.S. will be seen as a pariah in the global community if it does not play a collaborative role in preventing the next ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

AUSTIN, Texas, Feb. 4, 2025 /PRNewswire/ -- Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, today announced that the company will host an ...

The Swiss pharma giant said that the topline data from its Lp((a))HORIZON study for IONS' RNA-targeting therapy pelacarsen are now anticipated in H1 2026 before regulatory submissions, expected in ...

Entresto is facing a strong generic threat, with at least four copycats approved by the FDA. Of these, the one developed by MSN Pharmaceuticals has been at the center of a fierce legal fight, with ...